Up about 12%, Tempus AI (NASDAQ:TEM) has been explosive. Helping, its volume just spiked to 18.6 million shares, as compared ...

David R. Epstein, a director at Tempus AI , Inc. (NASDAQ:TEM), recently sold 370 shares of the company's Class A Common Stock. The shares were sold on February 3, 2025, at an average price of $53.31 ...

We recently compiled a list of the 10 Firms Shine Amid Market Slump. In this article, we are going to take a look at where ...

Tempus AI has delivered an 82% YTD return, outperforming the broader market and AI-themed stocks amidst market volatility.

TD Cowen analyst Dan Brennan reinstated coverage of Tempus AI (TEM) with a Buy rating and price target of $74, up from $58, following the ...

We recently published a list of Top 10 AI Stocks Trending On Wall Street. In this article, we are going to take a look at where Tempus AI, Inc.

Let's explore the Tempus AI stock price and whether it is a good company to buy and hold despite its overvaluation.

Tempus AI's innovative products are transforming the healthcare industry, with a focus on oncology and large market ...

So, when the former Speaker placed a not-insignificant call options wager on TEM stock last month, momentum erupted. Over the trailing one-month period, TEM has gained almost 51% of equity value.

Looking at options history for Tempus AI TEM we detected 21 trades. If we consider the specifics of each trade, it is ...

Coming to the latest development around Olivia, the investors are optimistic, evident from the stock surge last week.

Tempus AI (TEM) is soaring 13% today after investment bank TD Cowen reinstated coverage of the shares with a Buy rating. TEM ...